Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

42.93
Delayed Data
As of 3:59pm ET
 +1.29 / +3.10%
Today’s Change
34.68
Today|||52-Week Range
55.15
+10.93%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Gano Kyle
Chief Business Development Officer
Sale4/11/201639,845$44.04$1.8M-4.89%
Obrien Christopher Flint
Chief Medical Officer
Sale11/15/201625,000$52.84$1.3M-21.33%
Obrien Christopher Flint
Chief Medical Officer
Sale4/06/201625,000$45.00$1.1M-10.43%
Obrien Christopher Flint
Chief Medical Officer
Sale5/16/201625,000$45.00$1.1M-8.76%
Pops Richard F
Director
Sale5/25/201615,000$46.72$700.8K-10.57%
Obrien Christopher Flint
Chief Medical Officer
Sale5/31/201612,500$50.00$625.0K-16.13%
Obrien Christopher Flint
Chief Medical Officer
Sale8/15/201612,500$48.73$609.1K-14.55%
Rastetter William H
Director
Sale2/01/201710,750$42.28$454.5K-2.14%
Lloyd Smith Malcolm
Chief Regulatory Officer
Sale5/31/20169,000$50.00$450.0K-16.13%
Lloyd Smith Malcolm
Chief Regulatory Officer
Sale9/01/20169,000$50.00$450.0K-16.92%
Page of 6